Education
About Us
Working with TipRanks
Follow Us
Zylox-Tonbridge Medical Technology Co., Ltd. Class H (DE:818)
:818
Total Valuation
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has a market cap or net worth of €750.00M. The enterprise value is €5.27B.
Market Cap€750.00M
Enterprise Value€5.27B
Share Statistics
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has 322,400,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding322,400,760
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 1.90%.
Return on Equity (ROE)0.03
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)1.90%
Return on Capital Employed (ROCE)0.02
Revenue Per Employee894.26K
Profits Per Employee114.58K
Employee Count875
Asset Turnover0.23
Inventory Turnover1.08
Valuation Ratios
The current PE Ratio of Zylox-Tonbridge Medical Technology Co., Ltd. Class H is 35.68. Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s PEG ratio is 0.20.
PE Ratio35.68
PS Ratio0.00
PB Ratio1.90
Price to Fair Value1.15
Price to FCF-313.20
Price to Operating Cash Flow56.60
PEG Ratio0.20
Income Statement
In the last 12 months, Zylox-Tonbridge Medical Technology Co., Ltd. Class H had revenue of 782.48M and earned 100.26M in profits. Earnings per share was 0.31.
Revenue782.48M
Gross Profit559.89M
Operating Income60.91M
Pretax Income100.26M
Net Income100.26M
EBITDA65.30M
Earnings Per Share (EPS)0.31
Cash Flow
In the last 12 months, operating cash flow was 104.03M and capital expenditures -121.90M, giving a free cash flow of -17.87M billion.
Operating Cash Flow104.03M
Free Cash Flow-17.87M
Free Cash Flow per Share-0.06
Dividends & Yields
Zylox-Tonbridge Medical Technology Co., Ltd. Class H pays an annual dividend of €0.012, resulting in a dividend yield of ―
Dividend Per Share€0.012
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.75
52-Week Price Change89.74%
50-Day Moving Average1.87
200-Day Moving Average1.44
Relative Strength Index (RSI)61.44
Average Volume (3m)0.00
Important Dates
Zylox-Tonbridge Medical Technology Co., Ltd. Class H upcoming earnings date is Aug 20, 2025, TBA Not Confirmed.
Last Earnings DateMar 20, 2025
Next Earnings DateAug 20, 2025
Ex-Dividend DateJun 04, 2025
Financial Position
Zylox-Tonbridge Medical Technology Co., Ltd. Class H as a current ratio of 4.58, with Debt / Equity ratio of 2.93%
Current Ratio4.58
Quick Ratio3.96
Debt to Market Cap0.02
Net Debt to EBITDA-5.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Zylox-Tonbridge Medical Technology Co., Ltd. Class H has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Zylox-Tonbridge Medical Technology Co., Ltd. Class H EV to EBITDA ratio is 49.77, with an EV/FCF ratio of 0.00.
EV to Sales4.15
EV to EBITDA49.77
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has €1.28B in cash and marketable securities with ¥90.91M in debt, giving a net cash position of -€1.19B billion.
Cash & Marketable Securities€1.28B
Total Debt¥90.91M
Net Cash-€1.19B
Net Cash Per Share-€3.70
Tangible Book Value Per Share€9.50
Margins
Gross margin is 71.55%, with operating margin of 7.78%, and net profit margin of 12.81%.
Gross Margin71.55%
Operating Margin7.78%
Pretax Margin12.81%
Net Profit Margin12.81%
EBITDA Margin8.34%
EBIT Margin4.62%
Analyst Forecast
The average price target for Zylox-Tonbridge Medical Technology Co., Ltd. Class H is €2.10, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target€2.10
Price Target Upside-3.67% Downside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―